Terms: = Pancreatic cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Clinical Outcome
23 results:
1. Epigenetic upregulation of MNAT1 by SMYD2 is linked to PI3K/akt activation and tumorigenesis of pancreatic adenocarcinoma.
Xu Z; Liu Y; Pan Z; Qin L
Histol Histopathol; 2024 Feb; 39(2):263-277. PubMed ID: 37232506
[TBL] [Abstract] [Full Text] [Related]
2. A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation.
Yang Z; Xie H; Wan J; Wang Y; Zhang L; Zhou K; Tang H; Zhao W; Wang H; Song P; Zheng S
EBioMedicine; 2023 Jun; 92():104594. PubMed ID: 37167784
[TBL] [Abstract] [Full Text] [Related]
3. Activation of the PI3K-akt signaling pathway by SPARC contributes to the malignant phenotype of cholangiocarcinoma cells.
Deng S; Zhang L; Li J; Jin Y; Wang J
Tissue Cell; 2022 Jun; 76():101756. PubMed ID: 35217388
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in pancreatic Ductal Adenocarcinoma.
Zhang Y; Liu Q; Cui M; Wang M; Hua S; Gao J; Liao Q
Front Immunol; 2021; 12():774435. PubMed ID: 35046938
[TBL] [Abstract] [Full Text] [Related]
5. Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer.
Nicolle R; Blum Y; Duconseil P; Vanbrugghe C; Brandone N; Poizat F; Roques J; Bigonnet M; Gayet O; Rubis M; Elarouci N; Armenoult L; Ayadi M; de Reyniès A; Giovannini M; Grandval P; Garcia S; Canivet C; Cros J; Bournet B; Buscail L; ; Moutardier V; Gilabert M; Iovanna J; Dusetti N
EBioMedicine; 2020 Jul; 57():102858. PubMed ID: 32629389
[TBL] [Abstract] [Full Text] [Related]
6. Deoxycholic acid modulates the progression of gallbladder cancer through N
Lin R; Zhan M; Yang L; Wang H; Shen H; Huang S; Huang X; Xu S; Zhang Z; Li W; Liu Q; Shi Y; Chen W; Yu J; Wang J
Oncogene; 2020 Jun; 39(26):4983-5000. PubMed ID: 32514152
[TBL] [Abstract] [Full Text] [Related]
7. Single-Cell Immune Competency Signatures Associate with Survival in Phase II GVAX and CRS-207 Randomized Studies in Patients with Metastatic pancreatic cancer.
Nair N; Chen SY; Lemmens E; Chang S; Le DT; Jaffee EM; Murphy A; Whiting C; Müller T; Brockstedt DG
Cancer Immunol Res; 2020 May; 8(5):609-617. PubMed ID: 32132105
[TBL] [Abstract] [Full Text] [Related]
8. Valproic Acid Addresses Neuroendocrine Differentiation of LNCaP Cells and Maintains Cell Survival.
Giordano F; Naimo GD; Nigro A; Romeo F; Paolì A; De Amicis F; Vivacqua A; Morelli C; Mauro L; Panno ML
Drug Des Devel Ther; 2019; 13():4265-4274. PubMed ID: 31908413
[TBL] [Abstract] [Full Text] [Related]
9. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
Wang ZX; Deng TX; Ma Z
J Cell Biochem; 2019 Oct; 120(10):16416-16426. PubMed ID: 31297864
[TBL] [Abstract] [Full Text] [Related]
10. Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1.
Cao J; Li J; Sun L; Qin T; Xiao Y; Chen K; Qian W; Duan W; Lei J; Ma J; Ma Q; Han L
Mol Oncol; 2019 Feb; 13(2):228-245. PubMed ID: 30367545
[TBL] [Abstract] [Full Text] [Related]
11. Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma.
Abdel-Wahab R; Varadhachary GR; Bhosale PR; Wang X; Fogelman DR; Shroff RT; Overman MJ; Wolff RA; Javle M
J Hematol Oncol; 2018 May; 11(1):71. PubMed ID: 29843755
[TBL] [Abstract] [Full Text] [Related]
12. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
[TBL] [Abstract] [Full Text] [Related]
13. Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial.
Maltoni M; Scarpi E; Dall'Agata M; Zagonel V; Bertè R; Ferrari D; Broglia CM; Bortolussi R; Trentin L; Valgiusti M; Pini S; Farolfi A; Casadei Gardini A; Nanni O; Amadori D;
Eur J Cancer; 2016 Sep; 65():61-8. PubMed ID: 27472648
[TBL] [Abstract] [Full Text] [Related]
14. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
Int J Oncol; 2016 May; 48(5):1955-64. PubMed ID: 26935290
[TBL] [Abstract] [Full Text] [Related]
15. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.
Di Gangi IM; Mazza T; Fontana A; Copetti M; Fusilli C; Ippolito A; Mattivi F; Latiano A; Andriulli A; Vrhovsek U; Pazienza V
Oncotarget; 2016 Feb; 7(5):5815-29. PubMed ID: 26735340
[TBL] [Abstract] [Full Text] [Related]
16. Polymorphisms in epidermal growth factor receptor (EGFR) and akt1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.
Zhang X; Fan J; Li Y; Lin S; Shu P; Ni J; Qin S; Zhang Z
Tumour Biol; 2016 Jan; 37(1):1061-9. PubMed ID: 26269114
[TBL] [Abstract] [Full Text] [Related]
17. Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer.
Huang YJ; Frazier ML; Zhang N; Liu Q; Wei C
Dig Dis Sci; 2014 May; 59(5):968-75. PubMed ID: 24248418
[TBL] [Abstract] [Full Text] [Related]
18. Novel synthetic oleanane triterpenoid AMR-MeOAc inhibits K-Ras through ERK, akt and survivin in pancreatic cancer cells.
Rabi T; Venkatanarashiman M
Phytomedicine; 2014 Mar; 21(4):491-6. PubMed ID: 24215674
[TBL] [Abstract] [Full Text] [Related]
19. Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae.
Aravindan S; Delma CR; Thirugnanasambandan SS; Herman TS; Aravindan N
PLoS One; 2013; 8(4):e61977. PubMed ID: 23613993
[TBL] [Abstract] [Full Text] [Related]
20. Ultraviolet enhances the sensitivity of pancreatic cancer cells to gemcitabine by activation of 5' AMP-activated protein kinase.
Adachi S; Yasuda I; Kawaguchi J; Yamauchi T; Nakashima M; Itani M; Nakamura M; Yoshioka T; Moriwaki H; Kozawa O
Biochem Biophys Res Commun; 2011 Oct; 414(1):53-9. PubMed ID: 21945432
[TBL] [Abstract] [Full Text] [Related]
[Next]